Search / 33 results found

from
to

The Supreme Court is considering a new abortion case affecting women across the U.S. Abortion opponents want the high court in arguments Tuesday to ratify a ruling from a conservative federal appeals court that would limit access to a medication called mifepristone, which was used in nearly two-thirds of abortions last year. The case comes two years after the Supreme Court overturned Roe v. Wade, enabling bans or severe restrictions on abortion in many Republican-led states. A decision should come by late June. Like the 2022 ruling, this decision could become a political campaign issue. Mifepristone is made by New York-based Danco Laboratories. An early ruling from a U.S. district court judge in Texas would've revoked the drug’s approval.

  • Updated

FILE - Boxes of the drug mifepristone sit on a shelf at the West Alabama Women's Center in Tuscaloosa, Ala., on March 16, 2022. The Supreme Court will again wade into the fractious issue of abortion when it hears arguments Tuesday, March 26, 2024, over mifepristone, a medication used in the most common way to end a pregnancy, for a case with profound implications for millions of women no matter where they live in America and, perhaps, the race for the White House. (AP Photo/Allen G. Breed, File)

  • Updated

File - The Supreme Court is seen on Friday, April 21, 2023, in Washington. The Supreme Court will again wade into the fractious issue of abortion when it hears arguments Tuesday, March 26, 2024, over mifepristone, a medication used in the most common way to end a pregnancy, for a case with profound implications for millions of women no matter where they live in America and, perhaps, the race for the White House. (AP Photo/Alex Brandon, File)

  • Updated

FILE - People march through downtown Amarillo to protest a lawsuit to ban the abortion drug mifepristone, Feb. 11, 2023, in Amarillo, Texas. The Supreme Court will again wade into the fractious issue of abortion when it hears arguments Tuesday, March 26, 2024, over mifepristone, a medication used in the most common way to end a pregnancy, for a case with profound implications for millions of women no matter where they live in America and, perhaps, the race for the White House. (AP Photo/Justin Rex, File)

  • Updated

FILE - Boxes of the drug mifepristone sit on a shelf at the West Alabama Women's Center in Tuscaloosa, Ala., on March 16, 2022. On Tuesday, March 26, 2024, the U.S. Supreme Court will take up a case that could impact how women get access to mifepristone, one of the two pills used in the most common type of abortion in the nation. (AP Photo/Allen G. Breed, File)

The U.S. Supreme Court will take up a case Tuesday that could impact how women get access to mifepristone. That's one of the two pills used in the most common type of abortion in the nation. The case centers on whether the Food and Drug Administration overlooked serious safety problems when it made the drug easier to obtain, including through mail-order pharmacies. Legal briefs in the case vary widely when it comes to descriptions of the pill’s safety. Medical researchers and the FDA say the chance of severe problems from the pill is very small.

Allergy season in the U.S. is starting sooner than experts expected. Experts say climate change is leading trees and grasses to pollinate longer and more intensely. That means more days of stuffy noses and itchy eyes for more than 80 million Americans. People can manage most symptoms by using over-the-counter medicines and knowing pollen levels. But if that doesn't work, experts suggest seeing a doctor who can determine what specific pollen you're allergic to.

Certain Medicare patients may get help paying for the popular weight-loss drug Wegovy, as long as they also have heart disease. The Centers for Medicare & Medicaid Services issued new gudiance that says Medicare Part D drug benefit plans can cover anti-obesity drugs as long as they're approved for an additional use. The guidance opens the door to wider coverage of Wegovy, which was approved to prevent the risk of heart attack, stroke and other serious heart problems in patients who are overweight or have obesity. Research showed that Wegovy cut the risk of those problems by 20% in such patients.

  • Updated

FILE - Donna Cooper holds up a dosage of Wegovy, a drug used for weight loss, at her home, March 1, 2024, in Front Royal, Va. The popular weight-loss drug Wegovy may be paid for by Medicare — as long as patients using it also have heart disease and need to reduce the risk of future heart attacks, strokes and other serious problems, federal officials said Thursday, March 21. (AP Photo/Amanda Andrade-Rhoades, File)

Millions of Americans who have used new obesity drugs like Wegovy to lose weight and improve health are wondering what happens if they stop taking them. Experts say the medications were designed and tested to be taken indefinitely to treat the disease of obesity. Some patients are experimenting with stretching out doses, taking the drugs intermittently or stopping and starting again only if needed. Doctors warn that the symptoms typically roar back even stronger, with more food cravings, hunger and weight regain. There's no data on the long-term effects of intermittent use.